Interesting facts
Interesting Facts About 2-Cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
This unique compound, with its intricate structure, belongs to the class of tetrazatricyclo compounds, which are fascinating due to their unique ring systems. Here are some compelling points about this compound:
- Structural Complexity: The molecule is characterized by a combination of cyclopropyl and tetrazole rings, leading to a 3-dimensional shape that can exhibit interesting steric and electronic properties.
- Biological Activity: Compounds of this nature have potential applications in pharmacology, particularly in drug discovery. The presence of nitrogen in the ring could contribute to unique biological interactions and mechanisms of action.
- Visualizing the Structure: Chemists often use molecular modeling software to visualize such complex structures. This aids in understanding the compound's reactivity and interaction with biological molecules.
- Research Interest: Due to their unusual properties, tetrazatricyclo compounds can be a subject of research to develop new materials or pharmaceuticals. Their implications in material science and medicinal chemistry are noteworthy.
- Historical Context: The synthesis of complex nitrogen-containing heterocycles like this one has intrigued chemists for decades, showcasing advancements in organic synthesis techniques.
As we delve deeper into the study of such intricate molecules, the potential for new discoveries continues to expand, making this compound an exciting area of focus for future research!
Synonyms
nevirapine
129618-40-2
Viramune
BI-RG-587
Nevirapine anhydrous
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
NVP
Viramune XR
BIRG 0587
BIRG587
Nevirapine, anhydrous
Nevirapine teva
11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one
BIRG-0587
Viramune (TN)
11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE
Nevirapina
BIRG-587
BI-RG 587
HSDB 7164
99DK7FVK1H
MFCD00866928
Nevirapinum anhydrous
NSC 641530
NSC-641530
DTXSID7031797
CHEBI:63613
Nevirapine [USAN:USP:INN:BAN]
NEVIRAPINE [MI]
CHEMBL57
NEVIRAPINE [INN]
NEVIRAPINE [JAN]
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one
11-CYCLOPROPYL-4-METHYL-5H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6(11H)-ONE
6H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-
NEVIRAPINE [HSDB]
NEVIRAPINE [USAN]
NSC641530
NEV
NEVIRAPINE [VANDF]
NEVIRAPINE [MART.]
NEVIRAPINE [WHO-DD]
BI RG 587
NEVIRAPINE [EMA EPAR]
MLS000084585
DTXCID9010787
NEVIRAPINE [ORANGE BOOK]
NEVIRAPINE [EP MONOGRAPH]
NEVIRAPINE [USP IMPURITY]
NEVIRAPINE [USP MONOGRAPH]
NEVIRAPINE ANHYDROUS [USP-RS]
NEVIRAPINE ANHYDROUS [WHO-IP]
2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
NCGC00065890-02
SMR000048458
NEVIRAPINUM ANHYDROUS [WHO-IP LATIN]
NEVIRAPINE (MART.)
NEVIRAPINE (EP MONOGRAPH)
NEVIRAPINE (USP IMPURITY)
NEVIRAPINE (USP MONOGRAPH)
Nevirapine (USAN:USP:INN:BAN)
NEVIRAPINE ANHYDROUS (USP-RS)
Viramune(TM)
2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-10-one
CAS-129618-40-2
Nevirapine & CD4-IgG
Nevirapine & PRO 140
UNII-99DK7FVK1H
nevirapinum
Nevirapine (JAN/USP/INN)
Nevirapine)
11-cyclopropyl-4-methyl-5H-dipyrido[[?],[?]][1,4]diazepin-6-one
BIRG 587
NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE
Viramune IR
1vrt
2hny
11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one
Nevirapine,(S)
BI-RG-587 & CD4-IgG
2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo(9.4.0.0^(3,8))pentadeca-1(15),3,5,7,11,13-hexaen-10-one
2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo(9.4.0.03,8)pentadeca-1(11),3,5,7,12,14-hexaen-10-one
6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE, 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-
Nevirapine (Standard)
Nevirapine (Viramune)
Nevirapine (anhydrous)
Opera_ID_934
SCHEMBL3318
MLS000759409
MLS001055309
MLS001201730
MLS001424058
MLS006011423
BIDD:GT0326
BDBM1434
BIRG0587
GTPL12676
J05AG01
Nevirapine for peak identification
HMS2051J09
HMS2231O23
HMS3264D21
HMS3371E03
HMS3393J09
HMS3655I08
HMS3715B10
Pharmakon1600-01503842
ALBB-027264
BCP05587
BSB41895
Tox21 110982
Tox21_110982
Tox21_200770
AC-643
AC1280
BBL010768
HY-10570R
NSC759902
STK580320
AKOS005504351
Tox21_110982_1
AB07544
CCG-100939
DB00238
KS-5019
NC00189
NN15304
NSC-759902
NCGC00065890-03
NCGC00065890-04
NCGC00065890-05
NCGC00065890-07
NCGC00065890-14
NCGC00258324-01
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one & PRO 140 (Anti-CCR5 monoclonal antibody)
HY-10570
N11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one & CD4-immunoadhesin
Nevirapine 100 microg/mL in Acetonitrile
SY009679
BI-RG 587;NSC 641530;NVP
DB-041930
N0922
NEVIRAPINE TABLETS FOR ORAL SUSPENSION
NS00004959
S1742
SW197569-2
C07263
D00435
EN300-119500
AB00393001-13
AB00393001-15
AB00393001_16
AB00393001_17
Q263713
BRD-K15502390-001-19-1
BRD-K15502390-001-20-9
F2173-0607
Z1521553473
BI-RG-587; BIRG 0587; BIRG587; HSDB 7164; NSC 641530; NVP
Nevirapine (anhydrous), European Pharmacopoeia (EP) Reference Standard
Nevirapine anhydrous, United States Pharmacopeia (USP) Reference Standard
Nevirapine, Pharmaceutical Secondary Standard; Certified Reference Material
11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido-[3,2-b:2',3'-e][1,4]diazepin-6-one
11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b :2',3'-e][1,4 ]diazepin-6-one
11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepin-6-one
11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2', 3'-e][1,4]diazepin-6-one
6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-
Nevirapine for peak identification, European Pharmacopoeia (EP) Reference Standard
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2 inverted exclamation mark ,3 inverted exclamation mark -e][1,4]diazepin-6-one
2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0,3,8]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
603-345-0
Solubility of 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
The solubility of the compound 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one, with the molecular formula C22H26N6O, can be influenced by several factors:
Therefore, while the compound may show some degree of solubility in polar solvents, it is essential to conduct empirical testing to determine the precise solubility and potential applications. As the solubility characteristics could indicate interactions in biochemical systems, understanding how this compound behaves in various solvents is vital.